Michael Wick

Company: XenoSTART

Job title: Chief Scientific Officer

Seminars:

XenoSTART: The Superior Source for Clinically Relevant Cancer Models 12:30 pm

• Introducing XenoSTART and showcasing their 2500+ XPDX models fully annotated with clinical treatment data, genomic profiling, and drug efficacy results • Highlighting their panels of ER+ breast, prostate and hematologic models   • Presenting XPDX model licensing platform for industry and academic collaboratorsRead more

day: Day One Track A AM